347 related articles for article (PubMed ID: 30458251)
1. Neurological manifestations in Onchocerca volvulus infection: A review.
Hotterbeekx A; Namale Ssonko V; Oyet W; Lakwo T; Idro R
Brain Res Bull; 2019 Feb; 145():39-44. PubMed ID: 30458251
[TBL] [Abstract][Full Text] [Related]
2. The Pathogenesis of Nodding Syndrome.
Johnson TP; Sejvar J; Nutman TB; Nath A
Annu Rev Pathol; 2020 Jan; 15():395-417. PubMed ID: 31977293
[TBL] [Abstract][Full Text] [Related]
3. Nodding syndrome (NS) and
Lagoro DK; Arony DA
Pan Afr Med J; 2017; 28():1. PubMed ID: 29138647
[TBL] [Abstract][Full Text] [Related]
4. Baseline characterization of epilepsy in an onchocerciasis endemic area of the Democratic Republic of Congo.
Burfeind KG; Kashama JK; Bora BK; Murchison CF; Ramos-Crawford AL; Nseka MT; Kunyu SB; Okitundu DL; Mashukano NL; Banea JM; Boivin Michael J; Mwanza JK; Mumba D; Tshala-Katumbay DD
Brain Res Bull; 2019 Feb; 145():45-52. PubMed ID: 30468846
[TBL] [Abstract][Full Text] [Related]
5. Geospatial modeling of pre-intervention nodule prevalence of Onchocerca volvulus in Ethiopia as an aid to onchocerciasis elimination.
Shrestha H; McCulloch K; Hedtke SM; Grant WN
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010620. PubMed ID: 35849615
[TBL] [Abstract][Full Text] [Related]
6. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.
Gumisiriza N; Mubiru F; Siewe Fodjo JN; Mbonye Kayitale M; Hotterbeekx A; Idro R; Makumbi I; Lakwo T; Opar B; Kaducu J; Wamala JF; Colebunders R
Infect Dis Poverty; 2020 Mar; 9(1):12. PubMed ID: 32114979
[TBL] [Abstract][Full Text] [Related]
8. THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?
El-Bahnasawy MM; Morsy AT; Morsy TA
J Egypt Soc Parasitol; 2015 Dec; 45(3):639-54. PubMed ID: 26939243
[TBL] [Abstract][Full Text] [Related]
9. Report of the first international workshop on onchocerciasis-associated epilepsy.
Colebunders R; Mandro M; Njamnshi AK; Boussinesq M; Hotterbeekx A; Kamgno J; O'Neill S; Hopkins A; Suykerbuyk P; Basáñez MG; Post RJ; Pedrique B; Preux PM; Stolk WA; Nutman TB; Idro R
Infect Dis Poverty; 2018 Mar; 7(1):23. PubMed ID: 29580280
[TBL] [Abstract][Full Text] [Related]
10. Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection.
Abd-Elfarag G; Carter JY; Raimon S; Sebit W; Suliman A; Fodjo JNS; Olore PC; Biel KP; Ojok M; Logora MY; Colebunders R
Epileptic Disord; 2020 Jun; 22(3):301-308. PubMed ID: 32540799
[TBL] [Abstract][Full Text] [Related]
11. Case definitions for onchocerciasis-associated epilepsy and nodding syndrome: A focused review.
Van Cutsem G; Siewe Fodjo JN; Dekker MCJ; Amaral LJ; Njamnshi AK; Colebunders R
Seizure; 2023 Apr; 107():132-135. PubMed ID: 37023626
[TBL] [Abstract][Full Text] [Related]
12. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.
Colebunders R; Hendy A; Mokili JL; Wamala JF; Kaducu J; Kur L; Tepage F; Mandro M; Mucinya G; Mambandu G; Komba MY; Lumaliza JL; van Oijen M; Laudisoit A
BMC Res Notes; 2016 Mar; 9():182. PubMed ID: 27005304
[TBL] [Abstract][Full Text] [Related]
13. Onchocerciasis-associated epilepsy: an update and future perspectives.
Hadermann A; Amaral LJ; Van Cutsem G; Siewe Fodjo JN; Colebunders R
Trends Parasitol; 2023 Feb; 39(2):126-138. PubMed ID: 36528471
[TBL] [Abstract][Full Text] [Related]
14. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With
Zhan B; Bottazzi ME; Hotez PJ; Lustigman S
Front Cell Infect Microbiol; 2022; 12():869039. PubMed ID: 35444961
[TBL] [Abstract][Full Text] [Related]
15. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
16. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
17. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
18. Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
Colebunders R; Kaiser C; Basáñez MG; Olliaro P; Lakwo T; Siewe Fodjo JN
Int J Infect Dis; 2022 Mar; 116():302-305. PubMed ID: 35074518
[TBL] [Abstract][Full Text] [Related]
19. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
[TBL] [Abstract][Full Text] [Related]
20. Nodding syndrome, other forms of epilepsy, and the Nakalanga syndrome most likely directly or indirectly caused by Onchocerca volvulus.
Colebunders R; Suykerbuyk P; Jacob ST; van Oijen M
J Neurol Sci; 2017 Jan; 372():439-440. PubMed ID: 27745691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
